These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 13307722)

  • 1. The pathological anatomy of the nephrotic syndrome.
    Zollinger HU
    Postgrad Med J; 1969 Nov; 45(529):701-12. PubMed ID: 4902324
    [No Abstract]   [Full Text] [Related]  

  • 2. Estimation of the phospholipid phosphorus turnover time in man: studies in normal individuals, in patients with the nephrotic syndrome and in other types of hyperlipemia.
    MOSER HW; EMERSON K
    J Clin Invest; 1955 Aug; 34(8):1286-96. PubMed ID: 13242661
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on hyperlipidemia in nephrotic syndrome].
    PEZOLD FA
    Klin Wochenschr; 1959 Feb; 37(3):132-40. PubMed ID: 13642720
    [No Abstract]   [Full Text] [Related]  

  • 4. [Significance of the kidneys in the pathogenesis of nephrotic hyperlipemia].
    SCHIROSA G; GUARINI G
    Acta Med Scand; 1960 Feb; 166():97-105. PubMed ID: 14442826
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental reconstruction of metabolic pattern of lipid nephrosis: key role of hepatic protein synthesis in hyperlipemia.
    MARSH JB; DRABKIN DL
    Metabolism; 1960 Oct; 9():946-55. PubMed ID: 13767173
    [No Abstract]   [Full Text] [Related]  

  • 6. [Renal origin of hyperlipidemia in nephrotic syndrome].
    REUBI F; SCHMID A
    J Urol Medicale Chir; 1955; 61(5):304-10. PubMed ID: 13307722
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lipid metabolism in kidney diseases].
    Yoshitoshi Y; Naito C
    Naika; 1968 Oct; 22(4):824-30. PubMed ID: 4884620
    [No Abstract]   [Full Text] [Related]  

  • 8. Proteinuria, hyperlipidemia, and the kidney.
    Hutchison FN
    Miner Electrolyte Metab; 1993; 19(3):127-36. PubMed ID: 8232099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid and lipoprotein abnormalities in renal disease.
    Segura R; Gotto AM
    Perspect Nephrol Hypertens; 1976; 3():159-200. PubMed ID: 814531
    [No Abstract]   [Full Text] [Related]  

  • 10. Is the aggressive management of hyperlipidemia in nephrotic syndrome mandatory?
    Keane WF; St Peter JV; Kasiske BL
    Kidney Int Suppl; 1992 Oct; 38():S134-41. PubMed ID: 1405364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disturbances of lipid metabolism during nephrotic syndrome: physiopathology and treatment].
    Moulin B; Ollier J; Olmer M
    Nephrologie; 1992; 13(5):193-9. PubMed ID: 1470293
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.